Seoul
South Korea
5
2021-08-26
4
2025-08-26
These are the the leading inventors for applications assigned to Stemlab Inc.:
Stemlab Inc. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
A METHOD FOR DIRECT REPROGRAMMING OF URINE CELLS INTO NEURAL STEM CELLS USING SYNTHETIC MRNA
#2 | 2021-01-21 ✅ Patent 11,572,540 granted on 2023-02-07Method for inducing oligodendrocyte precursor cells from OCT4-induced human somatic cells through direct reprogramming
#3 | 2020-04-16METHOD FOR DIRECT REPROGRAMMING OF URINE CELLS INTO KERATINOCYTE STEM CELLS AND METHOD FOR PREPARING COMPOSITION FOR PROMOTING SKIN REGENERATION USING REPROGRAMMED KERATINOCYTE STEM CELLS
#4 | 2019-09-19 ✅ Patent 10,767,163 granted on 2020-09-08Method for inducing oligodendrocyte precursor cells from Oct4-induced human somatic cells through direct reprogramming
#5 | 2018-12-20 ✅ Patent 10,640,541 granted on 2020-05-05Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid
Also check out Stemlab Inc.'s (Seoul, South Korea) applicant profile with 4 patent applications submitted.
157076 ⎘